| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Roivant Sciences Ltd. | President and Vant Chair | Common Shares | 13,736,547 | $277,752,980 | $20.22 | 24 Dec 2025 | Direct |
| Immunovant, Inc. | Director | Common Stock | 835,039 | $16,667,378 | $19.96 | 01 Apr 2025 | Direct |
| Immunovant, Inc. | Director | Stock Option (right to buy) | 93,599 | 01 Apr 2025 | Direct | ||
| Arbutus Biopharma Corp | Director | Stock Option (Right to Buy) | 67,000 | 23 May 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ROIV | Roivant Sciences Ltd. | 23 Dec 2025 | 3 | +$2,479,180 | 4 | President and Vant Chair | 29 Dec 2025, 21:00 |
| ROIV | Roivant Sciences Ltd. | 30 Jul 2025 | 2 | $0 | 4 | President and Vant Chair | 01 Aug 2025, 21:12 |
| ROIV | Roivant Sciences Ltd. | 29 Jul 2025 | 0 | $0 | 3 | President and Vant Chair | 29 Jul 2025, 21:00 |
| IMVT | Immunovant, Inc. | 01 Apr 2025 | 2 | $0 | 4 | Director | 03 Apr 2025, 16:37 |
| ABUS | Arbutus Biopharma Corp | 23 May 2024 | 1 | $0 | 4 | Director | 24 May 2024, 16:07 |
| IMVT | Immunovant, Inc. | 02 Apr 2024 | 2 | $0 | 4 | Director | 04 Apr 2024, 16:44 |
| ABUS | Arbutus Biopharma Corp | 24 May 2023 | 1 | $0 | 4 | Director | 26 May 2023, 16:12 |
| IMVT | Immunovant, Inc. | 12 Apr 2023 | 2 | $0 | 4 | Director | 14 Apr 2023, 16:29 |
| IMVT | Immunovant, Inc. | 29 Sep 2022 | 1 | +$116,200 | 4 | Director | 29 Sep 2022, 16:21 |
| IMVT | Immunovant, Inc. | 17 Aug 2022 | 2 | $0 | 4 | Director | 19 Aug 2022, 16:39 |
| ABUS | Arbutus Biopharma Corp | 25 May 2022 | 1 | $0 | 4 | Director | 26 May 2022, 16:15 |
| IMVT | Immunovant, Inc. | 10 Jan 2022 | 2 | $0 | 4 | Director | 12 Jan 2022, 16:13 |
| ABUS | Arbutus Biopharma Corp | 03 Jun 2021 | 1 | $0 | 4 | Director | 07 Jun 2021, 16:24 |